NeoGenomics
NEO
244 hedge funds and large institutions have $1.02B invested in NeoGenomics in 2022 Q4 according to their latest regulatory filings, with 35 funds opening new positions, 86 increasing their positions, 76 reducing their positions, and 34 closing their positions.
150% more call options, than puts
Call options by funds: $5.08M | Put options by funds: $2.03M
13% more repeat investments, than reductions
Existing positions increased: 86 | Existing positions reduced: 76
3% more first-time investments, than exits
New positions opened: 35 | Existing positions closed: 34
0% more capital invested
Capital invested by funds: $1.02B → $1.02B (+$3.54M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
1% less funds holding
Funds holding: 247 → 244 (-3)
5.07% less ownership
Funds ownership: 94.23% → 89.16% (-5.1%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$18.5M |
| 2 |
EMFAT
Emerald Mutual Fund Advisers Trust
Leola,
Pennsylvania
|
+$8.26M |
| 3 |
BlackRock
New York
|
+$7.68M |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$7.61M |
| 5 |
GF
Greenhouse Funds
Baltimore,
Maryland
|
+$7.32M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
United Kingdom
|
-$54M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$27.6M |
| 3 |
FAM
Fred Alger Management
New York
|
-$8.22M |
| 4 |
Invesco
Atlanta,
Georgia
|
-$6.75M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$6.2M |
NEO Hedge Fund Activity: Q4 2022 in Review
244 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in NeoGenomics (NEO) for Q4 2022, worth a combined $1.02B — up 0.35% from $1.02B a quarter earlier.
Buyers outnumbered sellers: 35 funds opened new NEO positions and 34 closed out — a net gain of 1 holder — while 86 added to existing stakes and 76 trimmed.
The largest buyer was Millennium Management, adding an estimated $18.5M. The largest seller was Janus Henderson Group, cutting an estimated $54M.
- 244 institutional investors held NeoGenomics (NEO) as of Q4 2022, down from 247 in Q3 2022.
- Funds reported $1.02B of NeoGenomics stock for Q4 2022, up 0.35% quarter-over-quarter.
- 35 funds opened new NeoGenomics positions in Q4 2022 and 34 closed out, a net change of +1 holder.
- The largest NeoGenomics buyer in Q4 2022 was Millennium Management, an estimated $18.5M added.
- The largest NeoGenomics seller in Q4 2022 was Janus Henderson Group, an estimated $54M sold.
Based on aggregated 13F filings for Q4 2022.